Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
New investors in 2023 must understand the current market landscape. Familiarize yourself with essential tips and strategies to thrive in investing.
28,353 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
As markets swing between hype and fundamentals, SPHQ stands out for quality. This guide explores why SPHQ could be th...
Walmart's cautious forecast unsettles investors, pulling the S&P 500 lower as traders reassess retail margins and cos...
A Duke University professor warns that lidar sensors in America's self-driving fleets are vulnerable to spoofing and ...
Geopolitical headlines drove a rush to buy the dip, yet the rebound failed to materialize for many investors. The epi...
As Oracle doubles down on AI, market dynamics and debt concerns push billionaire wealth into sharp focus. Analysts de...
Morgan Stanley capped redemptions at a private income fund after a surge in withdrawals, fueling a Reddit-fueled sell...
Boeing’s June performance marks more than a monthly milestone. With 64 jets delivered, the company nudges its cash fl...
Six years after Bitcoin endured its COVID-era collapse, the market has staged a dramatic rebound. This piece examines...
Capital One’s stock sits near $184 after a wave of acquisitions and an earnings miss. Here’s what Wall Street expects...
In a choppy market shaped by inflation and global tensions, three stocks stand out for potential to beat market retur...
Institutional investors are eyeing Millrose Properties’ land-banking model as the housing market shifts. This look at...